partnership Archives -

On Tuesday, Curebase announced a three-year clinical trial partnership with Meru Health, the study looking at the effectiveness

Curebase & Meru Health unite for app-based mental health trial

https://pharmaphorum.com/news/curebase-meru-health-unite-for-app-based-mental-health-trial/

Partner Content/ Partner content/ Press releases

The ryze-elluminate integration to maximise automation in clinical trials

Lesley Gordon automation, clinical trials, eClinical, formedix, partnership 0 Comment

The ryze-elluminate integration

The ryze-elluminate integration to maximise automation in clinical trials

https://pharmaphorum.com/partner-content/the-ryze-elluminate-integration-to-maximise-automation-in-clinical-trials/

News/ News/ Oncology

GSK bails on $4.2bn partnership with Merck on cancer drug

Phil Taylor bintrafusp alfa, GlaxoSmithKline, immuno-oncology, Merck KGaA, Oncology, partnership 0 Comment

GlaxoSmithKline has ended its collaboration with Germany’s Merck KGaA’s cancer treatment bintrafusp alfa, after a trio of failed

GSK bails on $4.2bn partnership with Merck on cancer drug

https://pharmaphorum.com/news/gsk-bails-on-4-2bn-partnership-with-merck-on-cancer-drug/

Patients/ Views & Analysis/ Views and analysis

Blueprints for UK pharma-NHS joint working

Amanda Barrell ABPI, Joint Working, NHS, partnership 0 Comment

Joint working could hold at least part of the answer to getting the NHS back on its feet

Blueprints for UK pharma-NHS joint working

https://pharmaphorum.com/patients/pharma-nhs-joint-working-case-studies/

News/ News/ R&D

Gilead/Galapagos alliance hit again as IPF drug is binned

Phil Taylor fibrosis, Galapagos, Gilead Sciences, idiopathic pulmonary fibrosis, partnership, respiratory disease 0 Comment

Gilead and Galapagos’ much-trumpeted R&D alliance has suffered another setback with the abandonment of ziritaxestat after a late-stage

Gilead/Galapagos alliance hit again as IPF drug is binned

https://pharmaphorum.com/news/gilead-galapagos-alliance-hit-again-as-ipf-drug-is-binned/

2021-01 LinkedIn - Prescient and Bridgepoint

Appointments/ Partner content

Prescient Healthcare Group to Partner with Bridgepoint Development Capital

cmaffei@prescienthg.com biopharma, Biotech, healthcare, partnership, pharma 0 Comment

The partnership will further enhance the client value

Prescient Healthcare Group to Partner with Bridgepoint Development Capital

https://pharmaphorum.com/partner-content/prescient-healthcare-group-to-partner-with-bridgepoint-development-capital/

News/ News/ Oncology

Oxford BioTherapeutics to research cell therapies for Gilead’s Kite

Phil Taylor cell therapy, Gilead Sciences, immuno-oncology, Kite Pharma, Oncology, Oxford BioTherapeutics, partnership 0 Comment

Gilead Sciences’ Kite unit has teamed up with the UK’s Oxford BioTherapeutics (OBT) to develop a new clutch

Oxford BioTherapeutics to research cell therapies for Gilead’s Kite

https://pharmaphorum.com/news/oxford-biotherapeutics-to-research-cell-therapies-for-gileads-kite/

Digital/ News/ News

Blue Oak taps AI specialist Exscientia for CNS drug discovery

Phil Taylor artificial intelligence, Blue Oak Pharma, central nervous system, digital, exscientia, partnership, Psychiatry 0 Comment

US startup Blue Oak Pharma has joined a lengthening list of companies turning to Exscientia of the UK

Blue Oak taps AI specialist Exscientia for CNS drug discovery

https://pharmaphorum.com/news/blue-oak-taps-ai-specialist-exscientia-for-cns-drug-discovery/

News/ News/ R&D

Moderna broadens R&D scope with Vertex, Chiesi alliances

Phil Taylor Chiesi, cystic fibrosis, Moderna, partnership, pulmonary arterial hypertension, Vertex Pharma 0 Comment

All eyes may be on Moderna’s COVID-19 vaccine at the moment, but the US biotech hasn’t been idle

Moderna broadens R&D scope with Vertex, Chiesi alliances

https://pharmaphorum.com/news/moderna-broadens-rd-scope-with-vertex-chiesi-alliances/

Trending

partnership

Login